Daiwa Securities Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-57
Closed -$12K 1304
2021
Q1
$12K Hold
57
﹤0.01% 1039
2020
Q4
$7K Sell
57
-113
-66% -$12.7K ﹤0.01% 1040
2020
Q3
$17K Buy
170
+4
+2% +$460 ﹤0.01% 1007
2020
Q2
$15K Hold
166
﹤0.01% 1042
2020
Q1
$15K Hold
166
﹤0.01% 1029
2019
Q4
$17K Sell
166
-22
-12% -$2.47K ﹤0.01% 1029
2019
Q3
$22K Buy
188
+4
+2% +$607 ﹤0.01% 993
2019
Q2
$32K Hold
184
﹤0.01% 986
2019
Q1
$31K Sell
184
-7
-4% -$1.04K ﹤0.01% 972
2018
Q4
$19K Buy
191
+60
+46% +$7.87K ﹤0.01% 970
2018
Q3
$23K Hold
131
﹤0.01% 995
2018
Q2
$18K Hold
131
﹤0.01% 1014
2018
Q1
$15K Buy
+131
New +$16.5K ﹤0.01% 1005

Other funds holding GWPH

Daiwa Securities Group's GWPH Position: Q2 2021 in Review

Daiwa Securities Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 57 shares — an estimated $12K sold.

Daiwa Securities Group first reported a position in GWPH in Q1 2018 and held it in 13 quarters. The position peaked at $32K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Daiwa Securities Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 57 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $12K.
  • Daiwa Securities Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 13 quarters.
  • Daiwa Securities Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $32K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.